miRagen Therapeutics is a biopharmaceutical company discovering and developing innovative microRNA (miRNA)-targeting therapies to improve human health, specifically in disease areas of high unmet medical need. The Company leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance best-in-class technologies and high-potential drug candidates for its own pipeline or in conjunction with strategic partners.
HQBoulder, US
Size (employees)51 (est)
miRagen Therapeutics was founded in 2007 and is headquartered in Boulder, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

miRagen Therapeutics Office Locations

miRagen Therapeutics has an office in Boulder
Boulder, US (HQ)
6200 Lookout Rd.
Show all (1)
Report incorrect company information

miRagen Therapeutics Financials and Metrics

miRagen Therapeutics Revenue


Revenue (Q2, 2018)

7 m

Net income (Q2, 2018)

(13.4 m)

EBIT (Q2, 2018)

(13.5 m)

Market capitalization (20-Sep-2018)

173.3 m

Closing stock price (20-Sep-2018)


Cash (30-Jun-2018)

43.4 m


149.5 m
miRagen Therapeutics's current market capitalization is $173.3 m.
USDQ1, 2018Q2, 2018


4.8 m7 m

General and administrative expense

3 m5.7 m

R&D expense

6.4 m14.8 m

Operating expense total

9.4 m20.4 m
USDQ1, 2018Q2, 2018


78.1 m43.4 m

Accounts Receivable

4.8 m1.2 m

Current Assets

86.4 m81.2 m


589 k614 k
USDQ1, 2018Q2, 2018

Net Income

(4.7 m)(13.4 m)

Depreciation and Amortization

69 k138 k

Accounts Payable

(146 k)(445 k)

Cash From Operating Activities

(7.4 m)(11.9 m)
USDY, 2018


-11.1 x


-12.6 x

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

miRagen Therapeutics Online and Social Media Presence

Embed Graph
Report incorrect company information

miRagen Therapeutics Company Life and Culture

Report incorrect company information